Pre-release allocation now open — 45% pricing active
CJC-1295 DAC 5mg vial — front view

GH / Longevity Research

CJC-1295 DAC

Strength · 5mg

For research use only

Price · Single vial (AUD)

$169

$93

AUD

Limited research allocation

Pre-release pricing applied automatically at checkout

  • AU-based fulfilment
  • Discreet dispatch
  • Tracking provided
  • Secure checkout

Crypto settlement available at checkout.

Research Information

Compound profile

Neutral, scientific reference information provided for laboratory research contexts only.

Short Description

A synthetic GHRH analogue with drug affinity complex modification, studied in laboratory research.

Research Overview

Investigated in preclinical models for extended-half-life interaction with the GHRH receptor.

Mechanism of Interest

GHRH(1–29) analogue with a DAC group enabling reversible albumin binding, studied for prolonged plasma exposure in animal models.

Key Research Areas

  • GHRH receptor binding studies
  • Plasma half-life characterisation
  • Albumin-binding kinetics research
  • Comparative analogue pharmacology

Compliance Notice

For research use only. Not for human consumption. This product is not intended to diagnose, treat, cure, or prevent any disease.

Complete Your Research Set

Build a coordinated research set

Base Selection

Already selected

Common Research Pairing

Pre-selected

Extended Research Set

Optional

Selected Total

$157 AUD

For research use only. Items listed at standard AUD pricing — base product pricing is unchanged. Adjust the selection to suit your laboratory requirements.

Orders processed 24–48h
AU shipping
Discreet packaging
Tracking provided

Research Use Only. This product is supplied for laboratory research purposes only. Not intended for human or animal consumption, medical use, diagnostic use, therapeutic use, or performance enhancement.

CJC-1295 DAC

$93 AUD